Fundology

ETF · ALPS

0H6M ALPS Medical Breakthroughs ETF

ISIN US00162Q5936London Stock Exchange: 0H6MSS&C Technologies Holdings, Inc.

Latest close

LSE

$56.35

on

Ongoing charge
0.50% a year
Fund size
£114m

Source: TradingView, as of , at least 15 min delayed

At a glance

As of 05/10/2026, 0H6M (ALPS Medical Breakthroughs ETF, ISIN US00162Q5936) closed at $56.35 on the London Stock Exchange. Its ongoing charge is 0.50% a year (about £50 on £10,000). Over the five years to 05/10/2026 its total return was +30.9%, or +2.4% after UK CPIH inflation.

Past returns

Total return: the change in the fund’s value with any income reinvested, after its ongoing charges. Periods to .
3 years to 05/10/2026
+106.4%
+86.3% after inflation
5 years to 05/10/2026
+30.9%
+2.4% after inflation

£1,000 put in five years ago would have been worth about £1,309 on 05/10/2026 — about £1,024 in today’s spending power, once price rises are taken out. Past performance is not a guide to future returns.

Volatility and the largest fall need a longer record of this fund’s prices than we hold so far. They appear on this page once we do.

Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.

How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH

Charges compared with similar funds

The ongoing charge is taken from the fund’s value every day, so the returns on this page are already after it. Platform and dealing fees are charged separately.
Ongoing charge
0.50%
a year
On £10,000
£50
a year, roughly
Over five years
£248
of £10,000, before growth
Among 19 healthcare funds, share classes counted once
  • 16 charge less
  • 0 the same
  • 2 charge more

Ongoing charge of ALPS Medical Breakthroughs ETF 0.50% a year, as of 03/10/2026: 2 of the 18 other healthcare funds charge more, 0 the same and 16 less (share classes counted once).

Source: Fund ongoing charges via TradingView, as of

A lower charge is not a promise of a higher return: what the fund holds matters more. Charges are the fund’s own published ongoing charges figure.

Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up

In plain English

ALPS Medical Breakthroughs ETF is an exchange-traded fund (ETF) from ALPS, launched in 2014.

It tracks the S-Network Medical Breakthroughs Index.

You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.

Its ongoing charge is 0.5% a year — about £50 a year on every £10,000 invested, taken from the fund's value rather than billed to you.

Income from its investments is paid out to holders as cash, usually a few times a year.

Healthcare: Pharmaceutical, biotech and medical-equipment companies.

Terms:ETFIndex fundAccumulating or incomeShare classISIN

Key facts

Ticker
0H6M
ISIN
US00162Q5936
Provider
ALPS
Tracks
S-Network Medical Breakthroughs Index
Structure
ETF
An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
Income
Distributing, paid annual
Income is paid out to holders as cash, usually a few times a year.
Ongoing charge
0.50% a year · about £50 on £10,000
Fund size
£114m
Launched
Domicile
United States
Currency hedged
No
Price currency
USD
Category
Healthcare

Price chart

Closing price
$56.35−9.9% since 18/09/2026 · closing price
0H6M closing price: $62.54 on 18/09/2026, $56.35 on 05/10/2026 (−9.9%); low $56.35, high $62.54.

Since 18/09/2026, the closing price went from $62.54 on 18/09/2026 to $56.35 on 05/10/2026 (−9.9%). The lowest close shown was $56.35 on 02/10/2026 and the highest $62.54 on 18/09/2026.

Chart: closing prices we have recorded since 18/09/2026. Price only — income paid out is not included, so the line can end below the total return above.

Source: TradingView, as of , at least 15 min delayed

Five years of prices, and after inflation

3 weekly closes, from 18/09/2026 to 06/10/2026. The same history in October 2026 pounds, adjusted with ONS CPIH inflation.

Create a free account to see the 5-year price chart and the after-inflation chart

Sign-up takes an email address. There is no card to enter and nothing to pay.

How we work it out:Prices and returnsNAV and price

Questions people ask

What is the ongoing charge of 0H6M?

The ongoing charge of 0H6M is 0.50% a year — about £50 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of ALPS Medical Breakthroughs ETF 0.50% a year, as of 03/10/2026: 2 of the 18 other healthcare funds charge more, 0 the same and 16 less (share classes counted once).

What does 0H6M track?

0H6M tracks the S-Network Medical Breakthroughs Index.

Is 0H6M accumulating or distributing?

0H6M is distributing: income is paid out to holders as cash, usually a few times a year. It pays out annual.

What is the ISIN of 0H6M?

The ISIN of 0H6M is US00162Q5936. An ISIN identifies one exact share class of a fund; 0H6M is its ticker on the London Stock Exchange.

How has 0H6M done after inflation?

Over the five years to 05/10/2026 0H6M’s total return was +30.9%, or +2.4% after UK CPIH inflation. Past performance is not a guide to future returns.

Similar funds

More healthcare funds, largest first. Size is a fact, not a verdict.

Sources and dates

Prices
London Stock Exchange closes via TradingView, at least 15 minutes delayed, latest
Returns
TradingView reported returns (net asset value with income reinvested where available)
Inflation
ONS CPIH, latest month published
Charges
The fund’s ongoing charges figure, via TradingView
Identity
FCA Financial Instruments Reference Data System (FIRDS) and the issuer
Fund size
TradingView, converted to pounds at the latest ECB reference rate

Methodology:Data sourcesReturnsCategoriesAll methods

A machine-readable copy of this page: Markdown.